Cargando…

Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67

Background: Flat urothelial lesions comprise a spectrum of morphologic changes ranging from reactive atypia to carcinoma in situ (CIS). Urothelial dysplasia and CIS are associated with the recurrence and progression of urothelial carcinoma. Distinguishing CIS and dysplasia from reactive atypia based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asgari, Mojgan, Nabi Maybodi, Mahtab, Abolhasani, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004568/ https://www.ncbi.nlm.nih.gov/pubmed/27579290

Ejemplares similares

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
por: Yoo, Daeseon, et al.
Publicado: (2023)

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020)

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma
por: Viana, Aline de Oliveira Ribeiro, et al.
Publicado: (2020)

Coexistence of HER2, Ki67, and p53 in Osteosarcoma: A Strong Prognostic Factor
por: Mardanpour, Keykhosro, et al.
Publicado: (2016)

Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium
por: Shevra, CR, et al.
Publicado: (2015)

Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2017)

Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells
por: Dahlrot, Rikke H., et al.
Publicado: (2021)

The potential diagnostic utility of coexpression of Ki-67 and P53 in the renal biopsy in pediatric lupus nephritis
por: Rahbar, Mahtab H, et al.
Publicado: (2018)

Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies
por: Yildiz, Isil Z, et al.
Publicado: (2009)

Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett’s esophagus: a matched case–control study
por: Helminen, Olli, et al.
Publicado: (2022)

Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies
por: Mumtaz, Shazia, et al.
Publicado: (2014)

A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
por: Kar, Ketaki, et al.
Publicado: (2021)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases
por: Joensuu, Kristiina, et al.
Publicado: (2013)

Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
por: Sangwaiya, Ashok, et al.
Publicado: (2018)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
por: Alston, Erin L. J., et al.
Publicado: (2019)

Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
por: Vetterlein, Malte W., et al.
Publicado: (2017)

A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms
por: Qi, Gaoxiu, et al.
Publicado: (2023)

Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

EGFR/erb-1, HER2/erb-2, CK7, LP34, Ki67 and p53 expression in preneoplastic lesions of bronchial epithelium
por: Carvalho, Lina, et al.
Publicado: (2010)

CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective
por: Akhtar, Mohammed, et al.
Publicado: (2020)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

Partial Oxygen Pressure Affects the Expression of Prognostic Biomarkers HIF-1 Alpha, Ki67, and CK20 in the Microenvironment of Colorectal Cancer Tissue
por: Zhang, Lirong, et al.
Publicado: (2016)

Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma
por: Cojocaru, Anca, et al.
Publicado: (2022)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China
por: Song, Qingbin, et al.
Publicado: (2011)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
por: Fulawka, Lukasz, et al.
Publicado: (2022)

Evaluation of P53 and CK20 Immunohistochemical Markers in Comparison with Morphologic Findings in Low- and High-grade Urothelial Carcinomas
por: Ahadi, Mahsa, et al.
Publicado: (2021)

Relationship between Ki-67 and CD44 expression and microvascular formation in gastric stromal tumor tissues
por: Ma, Bing, et al.
Publicado: (2022)

The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
por: Sarafoleanu, D, et al.
Publicado: (2009)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b27tco0snatmsr25mlkcvdkse8